Application of tumor marker analysis to patients with lung cancer

Détails

ID Serval
serval:BIB_817D16AF02DA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Application of tumor marker analysis to patients with lung cancer
Périodique
Schweizerische Medizinische Wochenschrift
Auteur(s)
Dent  P. B., Louis  J. A., McCulloch  P. B., Dunnett  C. W., Cerottini  J. C.
ISSN
0036-7672 (Print)
Statut éditorial
Publié
Date de publication
06/1979
Volume
109
Numéro
22
Pages
827-30
Notes
Journal Article --- Old month value: Jun 2
Résumé
Measurement of Clq-BA and CEA levels in patients with lung cancer may provide additional information about their clinical status discriminating between disease free patients and those with residual disease. Post-operative determination of Clq-BA and CEA levels may assist in defining patients which have poor prognosis. Preliminary evidence suggests that Clq-BA measurement may provide additional prognostic information in a small group of patients with normal CEA values. Finally, the presence of elevated Clq-BA in tumor bearing patients is of fundamental importance in the biology of cancer as it suggests that there are some tumor associated antigens which provoke the production of antibody in the host with the resultant formation of circulating immune complexes. The definition of the nature of the antigen in these immune complexes awaits further study.
Mots-clé
Carcinoembryonic Antigen/*analysis Humans Lung Neoplasms/*diagnosis/immunology
Pubmed
Web of science
Création de la notice
28/01/2008 12:14
Dernière modification de la notice
03/03/2018 18:48
Données d'usage